This is a national multicenter study in Norway investigating of individuals with Covid-19 vaccine associated myocarditis (VAM) and pericarditis in Norway. The main objective is to validate the reported possible cases of Covid-19 vaccine associated myo-and pericarditis in Norway as well as investigate for predisposing factors and risk factors for developing these vaccine adverse events. Furthermore, patients with confirmed Covid-19 VAM, will be invited to participate in a prospective cohort study, investigating for cardiac long-term adverse effects 1 year and 2 years after vaccine-associated myocarditis.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Presence of myocardial scar
Timeframe: 1 year post myocarditis
Reduced myocardial function
Timeframe: 1 year post myocarditis
Presence of supraventricular arrhythmias
Timeframe: 1 year post myocarditis
Presence of ventricular arrhythmias
Timeframe: 1 year post myocarditis
Persisting cardiac symptoms.
Timeframe: 2 years post myocarditis
All cause death
Timeframe: 1 year post myocarditis